Cover Image

In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products

This study aims to assess the in vitro activity of different samples of cefoperazone/sulbactam (CFP/SUL) against multidrug-resistant organisms (MDROs). Clinical isolates of extended-spectrum β-lactamase (ESBL)-<i>Escherichia coli</i>, ESBL-<i>Klebsiella pneumoniae</i>...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ming-Jen Sheu (Author), Chi-Chung Chen (Author), Ying-Chen Lu (Author), Bo-An Su (Author), Chun-Cheng Zhang (Author), Shu-Shen Wang (Author), Yin-Ching Chuang (Author), Hung-Jen Tang (Author), Chih-Cheng Lai (Author)
Format:	Book
Published:	MDPI AG, 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimal Dose of Cefoperazone-Sulbactam for Acute Bacterial Infection in Patients with Chronic Kidney Disease
by: Chien-Ming Chao, et al.
Published: (2022)

Hypersensitivity vasculitis induced by cefoperazone/sulbactam
by: Ariturk Ender, et al.
Published: (2003)

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam
by: Yan-Jing Qu, et al.
Published: (2016)

Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone-Sulbactam
by: Chien-Hsiang Tai, et al.
Published: (2022)

The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An In Vitro Study
by: Chih-Cheng Lai, et al.
Published: (2019)

Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
by: Ling Zhou, et al.
Published: (2019)

Comparing the Outcomes of Cefoperazone/Sulbactam-Based and Non-Cefoperazone/Sulbactam-Based Therapeutic Regimens in Patients with Multiresistant <i>Acinetobacter baumannii</i> Infections-A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2024)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
by: Xueting Wang, et al.
Published: (2023)

Activity Of Piperacillin/Tazobactam And Cefoperazone/Sulbactam Against Pathogenic Isolates Of Enterobacteriaceae
by: Qamar un nisa Naz, et al.
Published: (2024)

CLINICAL AND PHARMACOECONOMICAL EFFICIENCY OF CEFOPERAZONE + SULBACTAM IN CHILDREN, SUFFERING FROM CYSTIC FIBROSIS
by: E.B. Pavlinova, et al.
Published: (2006)

CLINICAL AND PHARMACOECONOMICAL EFFICIENCY OF CEFOPERAZONE + SULBACTAM IN CHILDREN, SUFFERING FROM CYSTIC FIBROSIS
by: E.B. Pavlinova, et al.
Published: (2006)

Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the Literature
by: Gowthami Sai Kogilathota Jagirdhar, et al.
Published: (2023)

Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study
by: Ruiqiu Zhang, et al.
Published: (2023)

The use of Pharmacokinetic and Pharmacodynamics to evaluate The recommended dosing regimens of Cefoperazone-Sulbactam in patients with hospital-Acquired Pneumonia
by: Narawadee Niamhun
Published: (2014)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Lei Zhang, et al.
Published: (2023)

Model-Informed Drug Development of New Cefoperazone Sodium and Sulbactam Sodium Combination (3:1): Pharmacokinetic/Pharmacodynamic Analysis and Antibacterial Efficacy Against Enterobacteriaceae
by: Xi-Wei Ji, et al.
Published: (2022)

Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
by: Frontiers Production Office
Published: (2024)

In Vitro Synergy of <i>Pongamia pinnata</i> Extract in Combination with Antibiotics for Inhibiting and Killing Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Po-An Su, et al.
Published: (2020)

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against <it>Acinetobacter baumannii </it>strains in terms of bactericidal efficacy and resistance selection
by: Gundes Sibel, et al.
Published: (2004)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against <i>Acinetobacter baumannii</i> in Patients with Hospital-Acquired Pneumonia
by: Yingjie Zhou, et al.
Published: (2022)

Cefoperazone induced hypersensitivity vasculitis
by: Katiyar Subodh, et al.
Published: (2009)

Cefoperazone induces esterase B expression by EstR and esterase B enhances cefoperazone activity at the periplasm
by: Neal Toewiwat, et al.
Published: (2020)

Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Ching-Yi Chen, et al.
Published: (2021)

Human Papillomavirus Deoxyribonucleic Acid Sequences and Clinical Outcomes of Cervical Cancer Patients Following Radiotherapy
by: Ching-Cheng Tseng, et al.
Published: (2004)

Policy, environment, and worksite fitness program participation among financial enterprise employees in Taiwan
by: Sheu-jen Huang, et al.
Published: (2016)

The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study
by: Chun-Chi Yang, et al.
Published: (2024)

The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan
by: Hung-Jen Tang, et al.
Published: (2022)

Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic
by: Hung-Jen Tang, et al.
Published: (2022)

Implant stability and marginal bone level changes: A 2-year prospective pilot study
by: Po-Sung Fu, et al.
Published: (2023)

AI-assisted literature exploration of innovative Chinese medicine formulas
by: Meng-Chi Chung, et al.
Published: (2024)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023)

Emergence and dissemination of multidrug-resistant Escherichia coli ST8346 coharboring blaNDM-5 and blaOXA-181 in Southern Taiwan, 2017-2021
by: Chia-Hung Tsai, et al.
Published: (2023)

Differential prevalence of hematuria and proteinuria with socio-demographic factors among school children in Hualien, Taiwan
by: Ming-Chun Chen, et al.
Published: (2018)

In Silico analysis unveils rs2109069 of DPP9 as a potential catalyst for COVID-19 severity and risk of inflammatory symptoms
by: Chi-Ying Lee, et al.
Published: (2024)

The possibility of recasting of pure titanium
by: Pei-Ling Lai, et al.
Published: (2017)

Immediate implant placement with and without provisionalization: A comparison of a one-year longitudinal study
by: Po-Sung Fu, et al.
Published: (2023)

Comparison of Various Solvent Extracts and Major Bioactive Components from Unsalt-Fried and Salt-Fried Rhizomes of <i>Anemarrhena asphodeloides</i> for Antioxidant, Anti-α-Glucosidase, and Anti-Acetylcholinesterase Activities
by: Yi-Cheng Chu, et al.
Published: (2022)

Fracture load of provisional fixed partial dentures with long-span fiber-reinforced acrylic resin and thermocycling
by: Wen-Cheng Chen, et al.
Published: (2009)

Radical trachelectomy for early stage cervical cancer: A case series and literature review
by: Chin-Jui Wu, et al.
Published: (2017)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Isolates
by: Fernando Pasteran, et al.
Published: (2021)